Organotypic 3D-cell-culture systems are implemented at various stages in the compound development process for de-risking new drug candidates and can provide a wealth of meaningful efficacy and toxicology data. A growing list of publications confirms the striking similarities of these systems to in vivo tissue, clearly underlining their high potential value to the pharmaceutical industry.
This workshop offers you an excellent way to get fully updated with the latest information on 3D-cell-culture technologies for toxicological and efficacy studies. Our expert team and invited guest speakers from SIRION BIOTECH GmbH, with their many years of combined experience, are in an unique position to provide you with information on different approaches to 3D culture and assays and the main issues affecting quality and costs in this segment of the industry today. In addition, the workshop gives you the opportunity to exchange views with academic and industry peers who are active and interested in the field of 3D cell culture.
| Date & Time: Monday 27 February 2012, 8.30 – 13.00 Venue: Arne Jacobsens Allé 15-17, 2300 Copenhagen S, Denmark Room: Auditorium Price: Free of charge (late cancellation/no-show fee DKK 375) Register For MVA-members only. Please register below. View if your organization is a member at www.mediconvalleyonline.com |
In collaboration with:
|
Program
| 08.30-09.00 | Registration, networking and coffee |
| 09.00-09.10 | Welcome Thomas Mortensen, Development Manager, Medicon Valley Alliance |
| 09.10-09.55 | 3D-cell-culture technologies, an overview Dr. Simon Messner, Product Manager Toxicology, InSphero AG |
| 09:55-10:25 | Microtissues in oncology Tony Rutt, Sales and Business Development Manager, InSphero AG |
| 10:25-10.45 | Coffee break |
| 10:45-11:15 | Organotypic cell models in toxicology Dr. Simon Messner, Product Manager Toxicology, InSphero AG |
| 11:15-11:40 | Improved cell based models for pharma and biotech industry – combining viral vector and cell technology Dr. Kathrin Schmitt, Director Key Accounts, SIRION BIOTECH GmbH |
| 11:40-12:05 | Viral vectors and cellular models for drug research – from 2D to 3D Dr. Christian Thirion, Chief Technology Officer, SIRION BIOTECH GmbH |
| 12:05-12:15 | 3D Hands-on session |
| 12:15-13:00 | Networking lunch |
For further information, please contact:
InSphero AG – Manuela Vujevic, Marketing Manager at manuela.vujevic@insphero.com or +41 44 5150 490
Medicon Valley Alliance – Thomas Mortensen at thomas.mortensen@mva.org or +45 3287 8008
About InSphero
InSphero is the leading, award-winning supplier of assay-ready 3D microtissues for drug discovery and in vitro toxicology. We offer single and multicell microtissues off-the-shelf, 1 x microtissue per well in standard plate format, helping you to improve data relevance and to reduce the overall cost of drug discovery. The company is headquartered in Zurich, Switzerland, and has established a solid customer base with more than ten global pharmaceutical and cosmetics companies. Read more about InSphero here.